
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+10
Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders
Neurodegenerative diseases,neurodegeneration,spinal cord injury,peptide,neuroprotection,neural repair,regeneration,drug,biotechnology,pharma,cns,neurology,als,parkinson,and multiple sclerosis
Axoltis pharma operates in the Biotechnology research industry.
Axoltis pharma's revenue is 11m - 100m
Axoltis pharma has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.